Preliminary results suggest that the immunosuppressive drug belatacept can help safely and effectively treat kidney transplant patients without the negative long-term side effects of traditional immunosuppressive regimens.
Click here for original story, New drug regimens improve outcomes for kidney transplant patients
Source: ScienceDaily